Renergen Ltd. (REN) - Total Liabilities
Based on the latest financial reports, Renergen Ltd. (REN) has total liabilities worth ZAC1.70 Billion ZAC (≈ $904.24K USD) as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Renergen Ltd. cash conversion from operations to assess how effectively this company generates cash.
Renergen Ltd. - Total Liabilities Trend (2013–2025)
This chart illustrates how Renergen Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check REN financial resilience to evaluate the company's liquid asset resilience ratio.
Renergen Ltd. Competitors by Total Liabilities
The table below lists competitors of Renergen Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Groupe Minoteries SA
SW:GMI
|
Switzerland | CHF45.97 Million |
|
RoyalTek Co Ltd
TWO:3306
|
Taiwan | NT$470.54 Million |
|
Western Energy Services Corp.
TO:WRG
|
Canada | CA$113.20 Million |
|
Kuantum Papers Limited
NSE:KUANTUM
|
India | Rs9.49 Billion |
|
Snowman Logistics Limited
NSE:SNOWMAN
|
India | Rs3.87 Billion |
|
ArcelorMittal South Africa Limited
JSE:ACL
|
South Africa | ZAC26.00 Billion |
|
Sypris Solutions Inc
NASDAQ:SYPR
|
USA | $92.51 Million |
|
Pelthos Therapeutics Inc.
NYSE MKT:PTHS
|
USA | $91.52 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Renergen Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see REN market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Renergen Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Renergen Ltd. (2013–2025)
The table below shows the annual total liabilities of Renergen Ltd. from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-02-28 | ZAC1.23 Billion ≈ $656.11K |
-11.06% |
| 2024-02-29 | ZAC1.39 Billion ≈ $737.66K |
+30.86% |
| 2023-02-28 | ZAC1.06 Billion ≈ $563.70K |
+20.75% |
| 2022-02-28 | ZAC878.38 Million ≈ $466.81K |
+53.04% |
| 2021-02-28 | ZAC573.95 Million ≈ $305.03K |
+51.33% |
| 2020-02-29 | ZAC379.26 Million ≈ $201.56K |
+523.00% |
| 2019-02-28 | ZAC60.88 Million ≈ $32.35K |
+33.53% |
| 2018-02-28 | ZAC45.59 Million ≈ $24.23K |
+28.00% |
| 2017-02-28 | ZAC35.62 Million ≈ $18.93K |
+18.32% |
| 2016-02-29 | ZAC30.10 Million ≈ $16.00K |
-57.93% |
| 2015-02-28 | ZAC71.55 Million ≈ $38.03K |
+4.86% |
| 2014-02-28 | ZAC68.23 Million ≈ $36.26K |
+9.87% |
| 2013-02-28 | ZAC62.11 Million ≈ $33.01K |
-- |
About Renergen Ltd.
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperatur… Read more